Group Action Lawyers
Latest News & Updates

Glaxo Wellcome UK Ltd is recalling four batches of Respontin Nebules due to results of impurities during a routine stability testing.

The batches are being recalled because of specification results for impurities being found during a routine stability testing. As far as the company is aware, there have been no adverse reactions from taking the drugs that have been reported.

But we all know how serious such small problems with medicines and medical products can be. Our Group Action Lawyers have been fighting for the rights of medical group cases for years, so know all too well how bad things can get…
Continue Reading…

Blood glucose monitors that are for home use are at risk of producing false low blood glucose level results.

It is the TRUEresult and TRUEtrack blood glucose test strips that are possibly producing these false results, which has triggered an MHRA Medical Device Alert.

If you use these devices, you should take heed of this warning, and contact a medical professional or doctor if you are concerned.
Continue Reading…

UPDATE: PLEASE NOTE THAT WE ARE NO LONGER ABLE TO ACCEPT NEW CASES IN THIS MATTER.

Corinthian Surgical Ltd issued a Field Safety Notice in March 2016 about bone reabsorbtion around granules implanted in the middle ear. Patients that were implanted with SerenoCem Granules for destruction of the mastoid cavity are possibly affected.

Patients did not show any symptoms, but reabsorbtion showed up on a CT scan. The reabsorbtion varied from being limited to extensive.

There are clinical risks associated with bone reabsorbtion in the middle ear such as inflammation (that can be infective), which can lead to infection and inflammation of the middle posterior fossa dura, facial nerve, and the inner ear. This can lead to more serious risk such as meningitis, loss of hearing, and facial palsy. However there have been no report of these complications.
Continue Reading…